HOME     |     CONTACT
	FDA Clearance of GRNOPC1

A new chapter in medical therapeutics — one that reaches beyond pills to a new level of healing:  the restoration of organ function achieved by the injection of healthy, functional replacement cells manufactured from human embryonic stem cells.		Video Illustration of GRNOPC1 in an Animal Model of Spinal Cord Injury
About GRNOPC1 1. Human Embryonic Stem Cells (hESCs) 2. Oligodendrocyte Progenitor Cells (GRNOPC1) 3. Preclinical Safety Studies 4. Clinical Program 5. Manufacturing 6. Intellectual Property	Webcast Geron Discusses FDA Clearance for World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy 01/23/2009,  6 am PT / 9 am ET	Video of GRNOPC1 Manufacturing
News Release Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy

Copyright © 2009 Geron Corporation. All rights reserved. 230 Constitution Drive, Menlo Park, CA 94025 USA. (650) 473-7700.